In February, Bristol-Meyers Squibb (NYSE:BMY) acquired Inhibitex (NASDAQ:INH).

FORBES: IPOs, FDA Approvals, and M&A Revive the Biotechnology Industry

In February BMY acquired Inhibitex (NASDAQ:INH).

FORBES: Pharmaceuticals Trading Near 52-Week Highs